Upgrade to SI Premium - Free Trial

Guggenheim Upgrades Sage Therapeutics (SAGE) to Buy

November 2, 2021 11:24 AM
Guggenheim analyst Yatin Suneja upgraded Sage Therapeutics (NASDAQ: SAGE) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Upgrades

Next Articles